Five Healthcare Startups Graduate from Inaugural NUS Medicine DHA 2024

Singapore’s newest healthcare innovation accelerator launches its first cohort—five startups tackling mental health, biotechnology, and clinical connectivity

The NUS Medicine Digital Advanced Technology Accelerator (DATA) hosted its inaugural Demo Day, showcasing five healthcare technology startups before investors, healthcare leaders, and strategic partners. The event marked a significant milestone for Singapore’s digital health ecosystem—the launch of a programme designed to bridge the gap between clinical innovation and commercial deployment.

Inaugural Cohort: Addressing Critical Healthcare Gaps

• TenangAI
  Mental health technology platform tailored for Gen Z and Millennials across Indonesia and Asia Pacific.
• HealthBridge AI
  AI-powered tools empowering physicians in clinical decision-making and healthcare delivery.
• 2Strands Biosciences
  Affordable blood tests for early cancer recurrence detection, enabling proactive treatment decisions.
• Health BETA
  Genetic testing and digital therapeutics preventing heart disease through personalised risk assessment.
• Marymount Labs
  Rapid clinical insight generation accelerating women’s health research and care decisions.

From Concept to Commercial Readiness

The inaugural cohort completed DATA’s structured programme focused on clinical validation with healthcare providers, business model refinement ensuring commercial viability, regulatory pathway navigation, and investor readiness preparation.

Demo Day provided graduating startups with crucial exposure to potential investors and strategic partners—connections essential for securing growth capital and scaling operations beyond Singapore.

Building Singapore’s Healthcare Innovation Infrastructure

The inaugural cohort demonstrates DATA’s role in supporting early-stage healthcare ventures through the challenging transition from development to commercialisation. By providing clinical expertise, regulatory guidance, and investor networks, the programme addresses the multidimensional challenges that prevent promising healthcare innovations from reaching patients.

Graduating startups continue receiving ecosystem support as they advance toward market deployment and regional expansion—reflecting DATA’s commitment beyond the formal programme timeline.